Net earnings from continuing operations attributable to AmSurg common shareholders were $0.55 per diluted share, or $17.5 million, compared to $0.56 per diluted share, or $17.8 million, in the first quarter of 2013.
“AmSurg’s results for the first quarter of 2014, which reflected a 2 percent decline in same-center revenues, were affected materially more by severe weather throughout the quarter than we anticipated in the guidance we established in late February,” said CEO Christopher Holden, according to the news release.
In the first quarter, AmSurg acquired one center and divested another. “We completed the first quarter of 2014 with seven letters of intent and had one de novo center under development, which we expect to open in 2015. With a robust pipeline of additional potential transactions, in addition to our letters of intent, we continue to expect to meet our center acquisition guidance for 2014,” said Mr. Holden, according to the report.
As of March 31, AmSurg owned and operated 242 centers.
More Articles on Transactions and Valuation Issues:
CON States: How to Open a De Novo ASC
MFC Announces April Dividend
4 Threats to ASC Case Volume Growth
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
